image

Cost-effectiveness acceptability curves of sugemalimab vs. placebo with and without PAP.

Authors
Publication date
1 June 2023
Publisher
Doi

    Abstract

    Cost-effectiveness acceptability curves of sugemalimab vs. placebo with and without PAP.</p

      Similar works

      Full text

      thumbnail-image

      Available Versions

      The Francis Crick Institute

      redirect
      oaioai:figshare.com:article/23279...
      Last time updated on 01/06/2023